Quantitative MRI for Prostate Cancer Detection and Monitoring
Dr. Tyler Seibert MD, PhD of the University of California, San Diego will present data regarding the use of “Quantitative MRI for Prostate Cancer Detection and Monitoring” at this year’s Radiological Society of North America (RSNA) conference in Chicago.
The presentation will take place on Wednesday, December 1, 2021, at 2 p.m. in the AI Theater in the south hall of McCormick Place Convention Center.
Read Dr. Seibert’s Bio
OnQ® Prostate
OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI), powered by AI, the software enables faster, more accurate PI-RADS scoring and improved inter-reader agreement.
OnQ Prostate: Multi-case study review demonstrating improved prostate cancer detection
Dr. Schwartzberg, MD uses OnQ Prostate to assess clinically significant prostate cancer. He first reviews the standard T2 imaging series, diffusion-weighted imaging series, (DWI), and apparent diffusion coefficient (ADC) map, then reviews the RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI can increase conspicuity and how, in this case, informs his designation of the PI-RADS number.
Contact Us
Would you prefer to add a date and time directly to a calendar? Click here to schedule a discovery meeting.
